$28.58 -0.83 (%) Medivation Inc - NASDAQ

Feb. 11, 2016 | 04:00 PM

Partner Headlines

  1. Microsoft, GoPro And 8 More Stocks To Watch Over The Weekend

    Benzinga | Feb. 6, 2016 | 13:59PM EST
  2. Medivation to Present at Leerink Partners 5th Annual Global Healthcare Conference

    GuruFocus | Jan. 27, 2016 | 23:05PM EST
  3. Journal of Clinical Oncology Publishes Results From the STRIVE Trial of Enzalutamide Compared ...

    GuruFocus | Jan. 26, 2016 | 23:05PM EST
  4. Weekly Insider Sells: Medivation, JPMorgan Chase, Stryker, Sabre

    GuruFocus | Jan. 26, 2016 | 13:13PM EST
  5. Lancet Oncology Publishes Results From the Phase 2 TERRAIN Trial of Enzalutamide Compared to ...

    GuruFocus | Jan. 13, 2016 | 23:04PM EST
  6. NanoString Technologies Enters Into Collaboration Agreement With Medivation and Astellas to ...

    GuruFocus | Jan. 7, 2016 | 23:01PM EST
  7. Medivation to Present at J.P. Morgan Healthcare Conference

    GuruFocus | Jan. 4, 2016 | 23:03PM EST
  8. Medivation Initiates Pivotal Clinical Trial of MDV9300 in Diffuse Large B-Cell Lymphoma

    GuruFocus | Dec. 21, 2015 | 23:07PM EST
  9. Wild Short Interest Swings For Three Top Biotech Stocks

    Benzinga | Oct. 28, 2015 | 07:57AM EST
  10. Medivation Announces Third Quarter 2015 Financial Results Teleconference on November 5, 2015

    GuruFocus | Oct. 23, 2015 | 00:03AM EST
  11. Medivation Announces Management Changes

    GuruFocus | Sep. 30, 2015 | 00:03AM EST
  12. Medivation Effects a Stock Dividend on Its Common Stock

    GuruFocus | Sep. 17, 2015 | 00:03AM EST
  13. Amgen And Biogen Lead Short Interest Surge In Biotechs

    Benzinga | Sep. 14, 2015 | 16:01PM EST
  14. A Portfolio To Support Cancer Treatments In Time For Prostate Cancer Awareness Month

    Benzinga | Sep. 8, 2015 | 16:05PM EST
  15. Medivation Announces Participation at Upcoming Investor Conference

    GuruFocus | Sep. 4, 2015 | 00:03AM EST
  16. Benzinga's Top Initiations

    Benzinga | Sep. 3, 2015 | 10:24AM EST
  17. Medivation to Expand Global Oncology Franchise With the Acquisition of All Worldwide Rights to ...

    GuruFocus | Aug. 25, 2015 | 00:02AM EST
  18. Benzinga's M&A Chatter for Monday August 24, 2015

    Benzinga | Aug. 24, 2015 | 18:44PM EST
  19. Medivation to Expand Global Oncology Franchise With the Acquisition of All Worldwide Rights to Talazoparib, a Potent PARP Inhibitor, From BioMarin

    Benzinga | Aug. 24, 2015 | 07:00AM EST
  20. Benzinga's Top #PreMarket Gainers

    Benzinga | Jul. 31, 2015 | 08:15AM EST
  21. Medivation Voted Three Years in a Row Among Top Workplaces in the San Francisco Bay Area

    GuruFocus | Jun. 30, 2015 | 00:03AM EST
  22. UPDATE: Medivation, Astellas Report Enrollment of First Patients in Advanced Prostate Cancer

    Benzinga | Jun. 17, 2015 | 07:05AM EST
  23. New Enzalutamide Data in Triple-Negative Breast Cancer Presented at the 2015 American Society of Clinical Oncology Annual Meeting

    Benzinga | Jun. 1, 2015 | 17:02PM EST
  24. Stocks: A Soft Jump On Jobs Data; WhiteWave, Boeing, NXP Climb

    IBD | May. 8, 2015 | 10:49AM EST
  25. Top Drugmaker Profits Mixed

    IBD | May. 7, 2015 | 18:51PM EST
  26. Medivation, Jazz Q1 Reports Miss; Regeneron Beats

    IBD | May. 7, 2015 | 18:43PM EST
  27. Four Hot Stocks You'll Want To Keep On Your Radar

    IBD | Feb. 27, 2015 | 17:44PM EST
  28. Nasdaq, S&P 500 Hang Tough; Avago, Akorn Big Earnings Winners

    IBD | Feb. 26, 2015 | 12:12PM EST
  29. Medivation Tops Q4 Views On Strong Xtandi Results

    IBD | Feb. 26, 2015 | 09:56AM EST
  30. Stocks Mixed; United Therapeutics Jumps To New High

    IBD | Feb. 25, 2015 | 14:59PM EST
  31. Market Edges Higher, Unfazed By Weak HP Results

    IBD | Feb. 25, 2015 | 13:31PM EST
  32. Market's Resilience Is Noteworthy; More Breakouts Emerge

    IBD | Feb. 25, 2015 | 11:55AM EST
  33. Earnings Scheduled For February 25, 2015

    Benzinga | Feb. 25, 2015 | 04:07AM EST
  34. Stocks Show Small Losses; Merger Talk Lifts Discovery

    IBD | Feb. 23, 2015 | 15:05PM EST
  35. Stocks Quietly Lower; Domino's, Medivation Break Out

    IBD | Feb. 23, 2015 | 13:18PM EST
  36. Wedbush Weighs in on Medivation Following Phase II TERRAIN Study Results

    GuruFocus | Feb. 3, 2015 | 12:50PM EST
  37. Valeant Agrees To Buy Dendreon's Provenge

    IBD | Jan. 30, 2015 | 11:39AM EST
  38. Weekly CEO Sells Highlight: QAD Inc, Orbitz Worldwide Inc, Constellation Brands Inc, and ...

    GuruFocus | Jan. 25, 2015 | 23:19PM EST
  39. Enzalutamide Phase 2 Terrain Trial Demonstrated Statistically Significant Increase in PFS as ...

    GuruFocus | Jan. 22, 2015 | 11:05AM EST
  40. J&J Earnings Beat, But Sales, Guidance Miss Estimates

    IBD | Jan. 20, 2015 | 11:20AM EST
  41. Eli Lilly Has 'Turned The Corner,' Upgraded

    IBD | Jan. 15, 2015 | 11:02AM EST
  42. Biotechs Presenting At The J.P. Morgan Healthcare Conference: Day 1

    Benzinga | Jan. 12, 2015 | 08:55AM EST
  43. Barclays Analyst Sees Biotech FY15 EPS Growth Outstripping Market

    Benzinga | Jan. 6, 2015 | 12:21PM EST
  44. William Blair's Top BioPharmaceutical Stock Picks for Q1 2015

    GuruFocus | Dec. 23, 2014 | 14:47PM EST
  45. Newly Profitable Medivation Riding High On Drug Sales

    IBD | Nov. 28, 2014 | 17:20PM EST
  46. Chip Stocks, Biotechs Lead Another Nasdaq Rally

    IBD | Nov. 24, 2014 | 14:58PM EST
  47. Major Upgrades And Downgrades In Friday's Market Action

    Benzinga | Nov. 7, 2014 | 15:30PM EST
  48. Medivation Hits High After Q3 Earnings Beat

    IBD | Nov. 7, 2014 | 11:15AM EST
  49. Medivation Hits High After Q3 Earnings Beat

    IBD | Nov. 7, 2014 | 11:15AM EST
  50. Medivation and Astellas Announce Phase 3 Study of Enzalutamide in Men With High-Risk, ...

    GuruFocus | Oct. 31, 2014 | 01:02AM EST
Trading Center